Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
|
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：332 / 334
页数：3
相关论文
共 47 条
  • [1] Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis
    Vandenberg, T.
    Younus, J.
    Al-Khayyat, S.
    CURRENT ONCOLOGY, 2010, 17 (02) : 56 - 57
  • [2] Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer
    Yu, Joanne L.
    Chan, Kelvin
    Kurin, Michael
    Pasetka, Mark
    Kiss, Alex
    Sridhar, Srikala S.
    Warner, Ellen
    BREAST JOURNAL, 2015, 21 (06) : 658 - 664
  • [3] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Ngamphaiboon, Nuttapong
    O'Connor, Tracey L.
    Advani, Pooja P.
    Levine, Ellis G.
    Kossoff, Ellen B.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1495 - 1501
  • [4] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Nuttapong Ngamphaiboon
    Tracey L. O’Connor
    Pooja P. Advani
    Ellis G. Levine
    Ellen B. Kossoff
    Medical Oncology, 2012, 29 : 1495 - 1501
  • [5] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [6] Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen
    Tarcha, Flavia Viecili
    Baccarin, Ana Luisa de Castro
    Barros, Lilian Arruda do Rego
    Alencar, Erika Bushatsky Andrade de
    del Giglio, Auro
    Cruz, Felipe Jose Silva Melo
    EINSTEIN-SAO PAULO, 2023, 21 : eAO0486
  • [7] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
    Fernandes, Ricardo
    Mazzarello, Sasha
    Stober, Carol
    Vandermeer, Lisa
    Dudani, Shaan
    Ibrahim, Mohamed F. K.
    Majeed, Habeeb
    Perdrizet, Kirstin
    Shorr, Risa
    Hutton, Brian
    Fergusson, Dean
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 1 - 10
  • [8] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [9] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
    Ricardo Fernandes
    Sasha Mazzarello
    Carol Stober
    Lisa Vandermeer
    Shaan Dudani
    Mohamed F. K. Ibrahim
    Habeeb Majeed
    Kirstin Perdrizet
    Risa Shorr
    Brian Hutton
    Dean Fergusson
    Mark Clemons
    Breast Cancer Research and Treatment, 2017, 161 : 1 - 10
  • [10] Fatal Clostridium septicum febrile neutropenia during adjuvant chemotherapy for early breast cancer
    Moreira-Pinto, Joao
    Passos-Coelho, Jose Luis
    Lopes, Fabio
    Ataide, Monica
    Oliveira, Paulo
    BMJ CASE REPORTS, 2020, 13 (05)
12345